20 March 2012
Akers Biosciences, Inc. ("ABI" or the "Company") Appointment of Joint Broker
Akers Biosciences Inc. (AIM: ABI) is pleased to announce that
Rivington Street Corporate Finance has been appointed as
Joint Broker to the Company, with immediate effect.
Thomas A. Nicolette President and CEO, Akers Biosciences, Inc
Tel. +1 856 848 8698
Daniel Stewart & Company plc (Nominated Adviser and Broker)
Noelle Greenaway, Corporate Finance
Martin Lampshire, Corporate Broking
Tel. +44(0)20 7776 6550
Jon Levinson
Rivington Street Corporate Finance
Tel. +44(0)20 7562 3357
About Akers Biosciences
Akers Biosciences, Inc. develops, manufactures, and supplies
rapid, point of care screening and testing products designed
to bring healthcare information both rapidly and directly to
the consumer or healthcare provider. The Company has advanced
the science of diagnostics while responding to major shifts
in healthcare through the development of several proprietary
platform technologies. The company's state